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Background: Accumulating evidence indicates that reactive oxygen species (ROS) are an important etiological
factor for the induction of dermal papilla cell senescence and hair loss, which is also known alopecia. Arctiin is an
active lignin isolated from Arctium lappa and has anti-inflammation, anti-microbial, and anti-carcinogenic effects. In
the present study, we found that arctiin exerts anti-oxidative effects on human hair dermal papilla cells (HHDPCs).
Results: To better understand the mechanism, we analyzed the level of hydrogen peroxide (H2O2)-induced
cytotoxicity, cell death, ROS production and senescence after arctiin pretreatment of HHDPCs. The results showed
that arctiin pretreatment significantly inhibited the H2O2-induced reduction in cell viability. Moreover, H2O2-induced
sub-G1 phase accumulation and G2 cell cycle arrest were also downregulated by arctiin pretreatment. Interestingly,
the increase in intracellular ROS mediated by H2O2 was drastically decreased in HHDPCs cultured in the presence of
arctiin. This effect was confirmed by senescence associated-beta galactosidase (SA-β-gal) assay results; we found
that arctiin pretreatment impaired H2O2-induced senescence in HHDPCs. Using microRNA (miRNA) microarray
and bioinformatic analysis, we showed that this anti-oxidative effect of arctiin in HHDPCs was related with
mitogen-activated protein kinase (MAPK) and Wnt signaling pathways.
Conclusions: Taken together, our data suggest that arctiin has a protective effect on ROS-induced cell dysfunction
in HHDPCs and may therefore be useful for alopecia prevention and treatment strategies.
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Reactive oxygen species (ROS) are reactive oxygen-
containing endogenous byproducts that are produced
during normal metabolism and play pivotal roles in main-
taining homeostasis [1]. Under stressful environmental con-
ditions (e.g., ionizing radiation, ultraviolet (UV) radiation,
drugs, and smoke), the levels of ROS, including hydrogen
peroxide (H2O2), are significantly increased [2]. These ROS
subsequently activate various signaling molecules, including
p53 and mitogen-activated protein kinase (MAPK) to in-
duce cell growth arrest and apoptosis [3,4]. In skin, exogen-
ous ROS can cause cellular damage, impaired collagen* Correspondence: ansfgrc@konkuk.ac.kr
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unless otherwise stated.synthesis, and keratinocyte apoptosis, which are mainly ob-
served in aged skin [5]. One group reported that high ROS
levels are involved in the etiologies underlying vitiligo skin
disease and skin cancer [6]. Furthermore, accumulating evi-
dence supports the hypothesis that oxidative stress caused
by H2O2 is a key factor in the onset and progression of hair
loss, which is known as alopecia [7-9].
Alopecia is a hair loss skin disorder that typically causes
baldness [10]. It was originally defined as an age-dependent
or androgen-dependent mechanism in dermal papilla cells
(DPCs) [11]. However, clinical reports have demonstrated
that alopecia does not occur in an androgen-dependent
manner; there are also androgen-independent mechanisms,
including chemotherapy-dependent and stress-dependent
effects [9,12,13]. A growing number of studies have
shown that the levels of apoptosis and senescence are. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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with non-balding DPCs [7,14]. Interestingly, ROS has
been known as an important inducer of the androgen-
dependent and -independent alopecia [9]. The dermal
papillae of balding scalps showed higher levels of ROS
compared with non-balding scalp [15,16]. Moreover, in-
creased ROS levels were associated with decreased DPC
motility [7]. In addition, DPCs from balding scalp also ex-
hibited higher levels of cell senescence [7]. More recent
studies also demonstrated that cisplatin-induced alopecia
is mediated by ROS production and ROS-mediated apop-
tosis in DPCs [17]. These finding have led to the hypoth-
esis that ROS may be an important target when designing
therapeutic strategies to prevent or treat alopecia.
Arctiin is a lignin chemical reagent isolated from
Arctium lappa. This chemical reagent has been known
to exert anti-inflammatory, anti-proliferative, and anti-
microbial effects [18-21]. We recently reported that arctiin
has a protective effect against UVB radiation in skin cells,
including dermal fibroblasts and keratinocytes [22,23]. We
subsequently observed that the arctiin-mediated anti-
photoaging effect is functionally related with microRNA
(miRNA)-mediated signaling pathways [22,23]. However,
it is unknown whether arctiin exerts anti-oxidative effects
and what biological effects arctiin has on human follicle
cells. In present study, we studied the biological events of
human hair dermal papilla cells (HHDPCs) in the pres-
ence of arctiin and/or H2O2 and performed cell-based as-
says to determine whether H2O2-induced cell dysfunction
could be inhibited by arctiin treatment. We also investi-
gated the role of miRNA-mediated mechanisms in using
microarrays and bioinformatic analysis.Results
Arctiin inhibits H2O2-mediated cell proliferation loss in a
dose-dependent manner in HHDPCs
Before we analyzed the inhibitory effect of arctiin against
H2O2-induced cell dysfunction, we preferentially soughtFigure 1 H2O2-mediated loss of HDPPC viability was rescued by arctii
with various doses of arctiin. Each bar represents the mean ± SD from thre
H2O2-induced cytotoxicity as measured with WST-1 assays. The graph repre
experiments. *p < 0.05 compared with H2O2-treated HHDPCs.to evaluate the effect of arctiin on HHDPC growth. First,
HHDPCs were exposed to different concentrations of arc-
tiin for 24 h, and cell viability was analyzed with WST-1
assays. As shown in Figure 1A, 10, 20, and 30 μM arctiin
significantly increased cell viability by 38.89 ± 3.99%,
42.48 ± 13.69%, and 48.96 ± 6.07% compared with di-
methyl sulfoxide (DMSO)-treated control cells. How-
ever, exposure to larger doses of arctiin (≥40 μM) did
not increase cell viability beyond that observed in cells
treated with 10 μM arctiin, and 60 μM arctiin induced
HHDPC cytotoxicity. Therefore, we concluded that an
arctiin dose of 10 to 30 μM arctiin has maximum growth-
promoting effect on HHDPCs, and those doses were used
in further experiments.
Next, we investigated the inhibitory effect of arctiin on
H2O2-induced cell dysfunction. We first performed WST-1
assays to analyze the inhibitory effect of H2O2 on HHDPC
viability. Cells were pretreated with 0 to 30 μM arctiin for
8 h and then stimulated with 750 μM H2O2. Cell viability
was analyzed after 24 h. As expected, arctiin pretreatment
attenuated the H2O2-induced decrease in cell viability in a
dose-dependent manner (Figure 1B). DMSO and H2O2-
treated cells showed a 38.15 ± 3.52% reduction in cell
viability compared with untreated cells; however, 10, 20,
and 30 μM arctiin-pretreated and H2O2-posttreated cells
showed only 13.95 ± 3.34%, 7.49 ± 4.40%, and 7.54 ± 2.68%
reductions compared with untreated cells, respectively.
These results indicate that arctiin attenuates H2O2-medi-
ated cytotoxicity in HHDPCs.Arctiin inhibits H2O2-mediated cell death and cell cycle
arrest in HHDPCs
To confirm the result shown in Figure 1B, we performed
cell cycle analyses using PI staining and flow cytometry.
HHDPCs were treated with arctiin and H2O2 under the
same conditions used for Figure 1B, and then cells were
stained with PI solution to analyze cell cycle patterns. As
shown in Figure 2A, arctiin and H2O2 treatment alteredn treatment. (A) WST-1 cytotoxicity assays of HHDPCs treated
e independent experiments. (B) Arctiin dose-dependently inhibited
sents the mean ± S.D. of relative cell viability from triplicate
Figure 2 H2O2-induced G2 arrest and cell death were rescued by arctiin. (A) HHDPCs were treated with DMSO or arctiin prior to H2O2
exposure, and cell cycle status was assessed flow cytometry. (B and C) The graphs represent the mean values of cell populations from three
independent experiments (sub-G1 and G1/G2, respectively). *p < 0.05 compared with control or H2O2-treated HHDPCs.
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only treatment led to accumulation of 7.45% in sub-G1,
12.84% in S phase and 7.45% in G2/M phase, with a
corresponding decrease in the percentage of G0/G1
phase cells as compared with untreated control cells
(Figure 2A). We also found that those accumulations in
sub-G1, S, and G2/M phases in H2O2-treated cells were
significantly decreased by arctiin pretreatment in a dose-
dependent manner. Pretreatment with 10 and 20 μM
arctiin led to reductions of 2.82% and 7.43% in sub-G1
phase cells as compared with H2O2-treated cells, re-
spectively, indicating that arctiin inhibited H2O2-medi-
ated sub-G1 accumulation, which is indicative of dead
cells (Figure 2B). Also, the proportion of G2/G1 cells
was increased by H2O2 treatment as compared with un-
treated control cells, indicating that H2O2 induced G2
arrest in HHDPCs (Figure 2C). However, the proportion
of G2 arrest cells was significantly decreased by arctiin
pretreatment (Figure 2C). Overall, these results suggest
that arctiin blocks H2O2-mediated cell death and G2 ar-
rest in HHDPCs.Arctiin inhibits H2O2-mediated ROS generation in HHDPCs
ROS generation mediated by H2O2 is characterized by
increases in cell death and cell cycle arrest in several cell
lines [1]. To determine whether arctiin pretreatment in-
hibits H2O2-mediated ROS generation, we performed
DCF-DA analyses to assess intracellular ROS production
in HHDPCs. As shown in Figure 3A, arctiin did not alter
intracellular ROS levels in untreated control cells, but it
significantly abolished the H2O2-induced increase in
intracellular ROS generation. Cells treated with 750 μM
H2O2 showed a 45.77% accumulation of M phase (DCF-
positive) cells as compared with untreated control cells
(Figure 3B). However, pretreatment with 20 μM arctiin,
led to reduction of 29.77% of cells in the M phase as com-
pared with H2O2-treated cells (Figure 3B). These resultssuggest that H2O2-mediated ROS production in HHDPCs
is inhibited by arctiin.Arctiin inhibits H2O2-mediated senescence in HHDPCs
Cell cycle arrest in the G2 phase and ROS generation
are functionally related with cellular senescence [24,25].
Therefore, we next determined whether G2 cell cycle ar-
rest and ROS generation contribute to senescence and
whether arctiin pretreatment can block H2O2-mediated
senescence in HHDPCs. Using SA-β-galactosidase (SA-β-
gal) assays, we evaluated cellular senescence by counting
the SA-β-gal-positive blue-stained senescent cells after arc-
tiin and/or H2O2 treatment under the same experimental
conditions shown in Figure 3A. H2O2 treatment increased
the percentage of senescent cells by 24.89% compared with
untreated control cells, however, 20 μM arctiin pretreat-
ment the percentage of senescent cells by 10.89% com-
pared with H2O2-treated cells (Figure 4). These results
indicate that arctiin negatively regulates H2O2-mediated
senescence in HHDPCs.Arctiin alters H2O2-mediated changes in miRNA expression
miRNAs are important small non-coding RNA molecules,
and exerts their biological functions by posttranscription-
ally regulating those of their target genes [26,27]. Numer-
ous studies have demonstrated that miRNAs regulate 4
major biological functions, such as development, prolifera-
tion, differentiation and apoptosis [28,29]. Furthermore,
accumulating results have shown that altered miRNA ex-
pression profiles are involved in UVB- or H2O2- protective
effects and even androgenetic alopecia in human skin cells
[23,30-32]. Therefore, we next sought to understand the
putative molecular mechanism underlying the protective
effect of arctiin against H2O2 in HHDPCs by analyzing
miRNA expression changes. We performed miRNA mi-
croarrays and identified 30 miRNAs that were differen-
tially expressed following arctiin pretreatment and H2O2
Figure 3 Analysis of intracellular ROS levels with DCF-DA assays. (A) HHDPCs were pre-treated with DMSO or arctiin (20 μM) followed by
H2O2 (750 μM) prior to flow cytometry. (B) The graph indicates the mean value of M1-phase (DCF-DA-stained) cells from three independent ex-
periments. *p < 0.05 compared with H2O2-treated HHDPCs.
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and 12 miRNAs were upregulated and downregulated
more than 2.0-fold, respectively (Table 1). The most dys-
regulated miRNAs were miR-602 (5.74-fold increase) and
miR-1290 (5.80-fold decrease). These findings indicateFigure 4 Effect of arctiin on H2O2-induced senescence as
measured by SA-β-gal assays. HHDPCs were pre-treated with DMSO
or arctiin (20 μM) followed by H2O2. The graph indicates the mean
value of senescent (SA-β-gal stained) cells from three independent
experiments. *p < 0.05 compared with H2O2-treated HHDPCs.that arctiin regulates the expression levels of specific miR-
NAs in HHDPCs.
To investigate the cellular effect of the altered miR-
NAs on HHDPCs, we selected the altered specific miR-
NAs and gathered the list of putative target mRNAs of
the miRNAs using a target prediction tool (MicroCosm
Targets ver. 5), and then determined the biological func-
tions associated with the target genes by Gene Ontology
(GO) analysis using AmiGO bioinformatic tools. Our data
show that arctiin has a protective effect against H2O2-
induced cellular senescence and apoptosis in dermal pa-
pilla cells; therefore, we analyze GO of the target genes and
categorize them into cellular processes including aging,
skin development, apoptosis and cell proliferation. As
shown in Tables 2 and 3, the altered miRNAs were func-
tionally related in the four biological categories. Mir-602
was the most upregulated miRNA and has many targets in-
cluding EDN1 and SOD2 (aging); APC (skin development);
ERBB4, PPARG, and TP53BP2 (apoptosis); and STAT3,
CDK9, and ID4 (cell proliferation). Mir-1290 was the most
downregulated miRNA and targets SLC1A2 (aging), APC
and COL8A1 (skin development), NOTCH1 and BMI1
(apoptosis), and ROBO1, CDC27 (cell proliferation).
Previous studies have indicated that arctiin-mediated
alterations in miRNAs may be involved in regulated the
four cellular mechanisms mentioned above. Also, as a
matter of fact, the GO term contains bi-directional pro-
cesses for each term. The term of ‘apoptosis’ includes
both anti-apoptotic and pro-apoptotic processes. There-
fore, GO analysis is not sufficient for understanding the
biological functions of altered miRNAs in our study. To
improve the accuracy of the biological meaning of the
Table 1 Significantly altered miRNAs (>2-fold change) following arctiin treatment of H2O2-exposed HHDPCs







hsa-miR-1181 2.13 Up 19 hsa-miR-874 2.97 Up 5
hsa-miR-125a-5p 5.04 Up 19 hsa-miR-890 2.83 Up X
hsa-miR-21-3p 2.82 Up 17 hsa-miR-939 2.59 Up 8
hsa-miR-29b-1-5p 3.12 Up 7 hsa-miR-1290 −7.56 Down 1
hsa-miR-3663-3p 2.19 Up 10 hsa-miR-1915-3p −2.63 Down 10
hsa-miR-3127-5p 2.01 Up 2 hsa-miR-2861 −3.31 Down 9
hsa-miR-3663-3p 2.03 Up 10 hsa-miR-3665 −2.37 Down 13
hsa-miR-371a-5p 3.14 Up 19 hsa-miR-4257 −3.62 Down 1
hsa-miR-4327 2.95 Up 21 hsa-miR-452-5p −2.54 Down X
hsa-miR-584-5p 2.31 Up 5 hsa-miR-513a-5p −3.15 Down X
hsa-miR-602 5.74 Up 9 hsa-miR-572 −5.80 Down 4
hsa-miR-629-3p 2.71 Up 15 hsa-miR-629-3p −3.03 Down 15
hsa-miR-642b-3p 2.10 Up 19 hsa-miR-765 −7.18 Down 1
hsa-miR-651 3.91 Up X hsa-miR-875-5p −3.91 Down 8
hsa-miR-762 2.84 Up 16 hsa-miR-940 −2.31 Down 16
Bae et al. Biological Research 2014, 47:50 Page 5 of 11
http://www.biolres.com/content/47/1/50target genes, the targets were analyzed using the Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway-
based enrichment analysis program in the bioinformatic
database DAVID. As shown in Tables 4 and 5, the al-
tered miRNAs may be involved in regulating pathways
involved in cancer, cell cycle, and Wnt and MAPK sig-
naling, among others. For example, miR-602 is putatively
involved in regulating MAPK and insulin signaling path-
ways; however, miR-1290 is involved in cancer, focal
adhesion, and insulin signaling pathways. Overall, the re-
sults indicate that the protective effect of arctiin against
H2O2-induced alterations in HHDPCs may be regulated
by arctiin-specific miRNAs and pathways that are possibly
affected by miRNAs.
Discussion
The identification of novel anti-oxidant chemo-reagents
is required to effectively treat or prevent alopecia due to
androgen dysregulation or oxidative stress. Here, we used
cell-based approaches, to demonstrate the potent anti-
oxidant activity of the lignin derivative arctiin. Interest-
ingly, pretreatment with arctiin drastically inhibited H2O2-
induced decreases in viability in HHDPCs. Flow cytometry
demonstrated that arctiin pretreatment also increased
HHDPC resistance against cell death and G2 cell cycle ar-
rest mediated by H2O2. Furthermore, those effects of arc-
tiin were related to its anti-oxidative effect. Upregulation
of intracellular ROS levels, which was mediated by H2O2,
was dramatically inhibited following arctiin pretreatment.
Recent reports have demonstrated that the loss of pro-
liferative capacity in balding dermal papilla cells is asso-
ciated with expression changes SA-β-gal and markers ofoxidative stress [7]. We also found that arctiin inhibited
H2O2-mediated upregulation of SA-β-gal activity in
HHDPCs. These findings suggest that arctiin is a novel
potent therapeutic agent for oxidative stress-induced
cell dysfunction in HHDPCs.
Using miRNA microarrays, we identified 30 miRNAs
that may have important roles in the arctiin-mediated
protective effect against H2O2 in HHDPCs. Although
further experiments are needed to validate miRNA expres-
sion levels to confirm the microarray data, we focused on
the biological meaning of the altered miRNAs in our study
because the cellular functions of miRNA are dependent
on their target mRNAs. Therefore, we used several bio-
informatic tools to understand the biological meaning of
the altered miRNAs. Our bioinformatical analysis showed
that the miRNAs altered in response to arctiin pretreat-
ment before H2O2 stimulation are commonly involved in
MAPK and Wnt signaling pathways. TAK1/MAP3K7 is a
member of the MAP3K family, and it has been reported
that impaired hair follicle morphogenesis and hair loss are
mediated by TAK1/MAP3K7 deletion in mice [33]. Also,
TAK1/MAP3K7 deficiency upregulates ROS levels, result-
ing in skin keratinocyte cell death [34]. Extracellular
signal-regulated kinase (ERK), a member of the MAPK
family, plays an important role in HHDPC proliferation.
ERK signaling is activated by minoxidil, which is a widely
used drug for treating androgenetic alopecia, and ERK in-
hibition blocks the anti-alopecia effect of the minoxidil
[35]. In addition, our bioinformatic results showed that
MAPK signaling was the most commonly targeted path-
way for the downregulated miRNAs mediated by arctiin in
HHDPCs (Table 5). This result indicates that MAPK
Table 2 Predicted targets of miRNAs upregulated by arctiin in H2O2-treated HHDPCs
miRNA
Target genes and functions
Aging Skindevelopment Apoptosis Cell proliferation
hsa-miR-1181 - - - -
hsa-miR-125a-5p EPO, EDN1, BCL2,
BAK1, CASP2,
PTH1R
COL4A3 ITCH, COL4A3, HIPK2, RAF1, EPO, EDN1,
BCL2, MAP2K7, MAP3K1, ARHGEF3,
TRAF6, CASP2, BAK1, IRF1, APPL1, ETS1,
BMF, MCL1, BCL2L2, BAG4, HK2, FOXQ1,
CREB1, E2F2, TP73, USP7, MAPK7, FGFR2,
BRCA1, MAP3K11, REST, DICER1,
ARHGEF2, MAP3K10, SORT1, BNIP2,
DDX5, CSNK2A1, MKNK2
BRCA1, MAP3K11, ETS1, LIF, SOX11,
CD34, NCOR2, BAP1, IRF1, APPL1, REST,
DICER1, EPO, EDN1, BCL2, BAK1,
ARHGEF2, FGFR2, ITCH, ABCB1, COL4A3,
KIF15, HIPK2, RAF1, EIF5A2, CARM1
hsa-miR-21-3p CDK6 - MAP2K4, MAP3K1, BCL2L11, ROBO2,
RNF41, BAG4, CUL3, FOXO3, SMAD3,
AMIGO2, KDM28, DAB2IP, TRIM32, SOX4,
CCAR1, SLC11A2, DSG1
CDK6, KDM28, CUL3, SOX4, SMAD3,
NR6A1, FTO, CD274, DAB2IP, TRIM32,
FOXO3, PBRM1
hsa-miR-29b-1-5p NR3C1, SIRT1 - NR3C1, SIRT1, REST, PTK2, SOS2, NUAK2,
PSMD7






CDKN1A, BCL11B, PPP2R1B, TGFB2,
DDX5, COMP, PIGT, FAS, USP28, TIAL1,
CASP2, PSMA2, MEF2D
FAS, USP28, TIAL1, TGFB2, CDKN1A,
BCL11B, VSIG
hsa-miR-371a-5p - LEF1, ATP7A,
COL8A1
LEF1, SOX2, CITED2, STK4, RB1CC1,
BARD1, RPS6KA1, GSK3B, PSMF1,
MAP3K1, NR4A2, DYRK2, ITSN1,
LEF1, SOX2, CITED2, STK4, COL8A1,
RNF10, MAPRE1, BTG3, CCR2, FRS2,
PRMT5
hsa-miR-4327 RPS6KB1 STS RPS6KB1, ADAMTS20, FGF10, IGF1R,
FGD4, RPS6KA3
RPS6KB1, IGF1R, FGF10, STS, PROX1, NF2,
IFNK
hsa-miR-584-5p SOD2, MORC3 PTCH2 SOD2, SIX1, LRP6, FGF10, TRIM24,
HDAC1, CUL2, SRPK2, NBN, ETS1, DSG3,
MTDH, PDE3A, SLAMF7
SOD2, SIX1, LRP6, FGF10, TRIM24,
HDAC1, CUL2, SRPK2, NBN, ETS1, PRRX1,
FER, USP8, WWTR1
hsa-miR-602 EDN1, VDR, SOD2,
HTT, SLC34A2,
CHEK1
APC EDN1, VDR, SOD2, HTT, APC, NOG,
ERBB4, PIM1, PPARG, ALDH1A2, CLI2,
SEMA3A, H1F0, DYRK2, BCL2L15, JMY,
PSMD2, TP53BP2, MYO18A, SHF
NOG, ERBB4, PIM1, PPARG, CLI2, CDK13,
LIFR, STAT3, EDN1, VDR, SOD2, CDC27,





BCL11B SERPINE1, BCL11B, PDCD10, HMGA2,
PTEN, RB1, CYLD, EIF2AK2, BCLAF1,
MAPK8, CDKN1A, WT1, CDK5R1, MTCH1,
EPHA7, NR4A3, CSNK2A1
SERPINE1, BCL11B, PDCD10, HMGA2,
PTEN, WT1, AMBN, CDKN1A, CDK5R1,
RB1, PAX6, NR2F2, PHOX2B
hsa-miR-651 - - BTC, MED1, ATG3, CHMP3 CTC, MED1
hsa-miR-762 RELA, PML - RELA, PML, MAPK1, SOX7, ITCH, HIPK2,
BCL6, PPARD, CX3CL1, AGAP2, MYO18A,
PAK4, ABR, CLIP3, ADD1, PAX7, ITGB2,
PDE1B, MAP3K9
EFNB1, LIFR, MMP14, BAP1, RELA, PML,
MAPK1, SOX7, PAK4, ITCH, HIPK2, BCL6,
CX3CL1, AGAP2, PPARD, NRARP, PTCH1,
WARS, FTO
hsa-miR-874 DDC - ESR1, ALDH1A2, HIPK2, PAK7, GZMB,
IKBKB, SORT1
ESR1, ALDH1A2, HIPK2, PAK7, RXRB,
COMT





SORT1, UBE2B, MAX, PEG3, F3, PDCD4,
TCF7L2, SNAI2, AIPL1, AKAP13, ALB, TRIO,
REST, PROK2, KRIT, NF1, APBB1, PSME2
F3, CDK6, TCF7L2, SNAI2, REST, PROK2,






NGFR, COL1A1 TNF, BCL6, BTC, NRG1, IHH, THRA, IP6K2,
PAX7, CASP10, CDKN1A, CAMK1D, TRAIP,
WNK3, CLIP3, MT3, INHBB, TIMP1, ATM,
NEK6, NGFR, NACC1, USP7, CSNK2A2,
BCL2L2
BCL6, BTC, NRG1, IHH, GRN, TRAIP,
CDKN1A, TNF, E2F8, RXRB, RARA, DRD2,
CSF1, TIMP1, ATM, NGFR, MT3, NOS2,
AGGF1, ELN
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However, our bioinformatic analysis revealed that the
MAPK signaling pathway is also targeted by the upregu-
lated miRNAs (Table 4), indicating that inhibition of
MAPK signaling pathway might be involved in protectiveeffects against ROS in HHDPCs. It has been reported that
ROS activates ERK/MAPK, and ROS-mediated ERK acti-
vation induces apoptosis and senescence in several cell
lines [36]. Although the molecular relationship between
alopecia and MAPK signaling pathway remains to be
Table 3 Predicted targets of miRNAs downregulated by arctiin in H2O2-treated HHDPCs
miRNA
Target genes and functions




APC, COL8A1 HMGA2, APC, RRN3, ITGAV, CSE1L,
NOTCH1, GAS, BMI1, FOXC1, ROBO1,
USP28
HMGA2, BMI1, NUAK1, APC, MLL2, RRN3,
ITGAV, CSE1L, NOTCH1, GAS, FOXC1,
ROBO1, USP28, CDC27, HES1, COL8A1,
NPR3, CDKN2B, FIGF, NRAS
hsa-miR-1915-3p BCL2, SRF, SREBF2,
HSD17B10
SRF, DDR1, EDA BCL2, MAPK311, ARHGEF2, CDK5R1,
WNT3A, MMP9, THRA, MEF2D, SET, CD44
DDR1, CDK2, DEAF1, TIRAP, BCL2,
MAP3K11, ARHGEF2, CDK5R1, WNT3A,
TNFSF11, WDR6, AZGP1, TAL1, DPT
hsa-miR-2861 P2PY2, FADS1 NGFR, EDA NGFR, PTPRC, ITGA1, MAEL, FGD2, AKT2,
PAX8
NGFR, PTPRC, SLAMF1, HOXB4, AKT2,
HOXB4,
hsa-miR-3665 AQP2 - AQP2, FGFR1, BOK, TRIO, NOTCH1,
PGAP2, PDPK1, BARD1
BOK, FEZF1, ABCB1, FOXO4, EIF5A2,
WNT9A, NDFIP1, FGFR1, NOTCH1, CDK13
hsa-miR-4257 TWIST1, CTSC,
HMGA1
COL2A1 TWIST1, CTSC, IGF1R, IL10, GSK3B,
RASSF5, COL2A1, AKT1S1, CD44, ASAH2
TWIST1, HMGA1, IL10, INSR, MAPRE2,
PA2G4, PRDM1, IGF1R, MMP14, EMX2,
TRIM27, MCM7
hsa-miR-452-5p TIMP3 - SPRY2, PAX3, SOX7, LRP6, SNAI2,
CSNK2A2, FGD4, PKN2, ITGA6, PDCD6IP
SPRY2, PAX3, SOX7, LRP6, SNAI2, RPA1,
EPS8, NFIB, MAPRE1, ODZ1, CDCA7L,








SPRY2, MLL, GATA3, BCL6, PRKCD, NEK6,
MED1, PLK2, WNT7A, SFN, APC, HOXA5,
AKAP13, USP47, MAP2K4, ISL1, MITF,
STAT1, XIAP, TFAP2B, HDAC2, TRIM2,
CREB1, MAP3K7, WNK3, SOS1, FGD4
TFAP2B, WNT7A, APC, HGF, EBXW7, TSC1,
KRAS, RXRB, XIAP, SPRY2, GATA3, BCL6,
HOXA5, ISL1, MITF, STAT1, NFIB, E2F7,
MAGI2, PDKK, HDAC2, MED1, EHF, LIFR,
PURA, GATA2, ATF3, VIP, SOX11, RUNX1,
RNF139, PCM1, TSHR, EPS8
hsa-miR-572 - - - -
hsa-miR-629-3p SOD2, VDR, EDN1,
CHEK1, SLC34A2
- THOC1, MYO18A, TP53BP2, SOD2, VDR,
EDN1, APC, PPARG, PIM1, ERBB4, PSMD2,
PERP, BCL2L15
DLG3, RTKN2, CDK9, STAT3, SOD2, VDR,
EDN1, PPARG, PIM1, ERBB4, APC, STAT6,
PDGFC, ZEB1, ID4, LIFR, NOLC1, EPHB1,
ACSL6, EREG, CDK13, CDC27
hsa-miR-765 VDR, RELA, SOCS3,
TIMP3, LOXL2
PDGFA, ERRFI1 DLG5, RARG, MED1, EGLN2, VDR, RELA,
SOCS3, ERBB4, RNF41, ATG7, ARHGEF11,
PDE5A, CXCL12, GLI3, DIDO1, CASP9,
ACIN1
CXCL12, GLI3, DLG5, RARG, VDR, RELA,
ERBB4, PDE5A, MED1, PDGFA, CD34,
GPC3, PDX1, COL8A1, PES1, TSC2, SF1,
FTO, GABBR1,
hsa-miR-875-5p TGFB3, SMC5 TCF7L2 TGFB3, TCF7L2, EYA1, MDM4, MEF2C,
EGFR, WNK3
MDM4, MEF2C, EGFR, FRS2, TGFB3, EYA1,
TOB2, TBX18, CEP120, TCF7L2, TIRAP,
RNF139, SALL1
hsa-miR-940 - - - -
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lating MAPK signaling might be important for treating or
preventing alopecia.
Our bioinformatic analysis also revealed that WNT
signaling pathway is putatively targeted by the miRNAs
altered following arctiin treatment. Wnt signaling has
also been implicated in alopecia. A recent study demon-
strated that Wnt10A, which is a member of the Wnt
family, is involved in the etiology of androgenetic alope-
cia [37]. A Wnt10A deficiency causes deregulation of
the hair cycle by shortening the anagen phase, which is
observed in androgenetic alopecia hair follicles [37].
Funato et al. demonstrated that H2O2-induced ROS can
regulate Wnt/β-catenin signaling pathways [38]. Also, it
was recently reported that the minoxidil-mediated anagen
prolongation effect is due to β-catenin pathway activation
[39]. Although further investigations are necessary toclarify the molecular interplay between ROS and Wnt
signaling pathway in hair follicles and in patients with
alopecia, our results suggest that arctiin-mediated anti-
oxidative effects in HHDPCs may be involved in regu-
lating Wnt signaling.Conclusions
In summary, our results demonstrate that arctiin regulates
H2O2-induced cell death, cell cycle arrest, and ROS pro-
duction in HHDPCs. Arctiin also inhibits H2O2-induced
cell senescence. We identified 30 miRNAs that were
significantly expressed following arctiin treatment, indicat-
ing that they may be involved in arctiin-mediated anti-
oxidative processes. Taken together, our results provide
evidence that the novel putative chemoreagent arctiin can
prevent HHDP cell damage mediated by oxidative stress.
Table 4 Main functions of upregulated miRNAs predicted by bioinformatic analysis
miRNA Putative




genes/total genes p-value(Homo sapiens)
miR-1181 2 - - - -
miR-125a-5p 162 Pathways in cancer 8 4.9 3.60E-02
Cell cycle 4 2.5 1.20E-01
miR-21-3p 210 Cell adhesion molecules 7 3.3 4.70E-03
Ubiquitin mediated proteolysis 6 2.9 2.30E-02
Oocyte meiosis 5 2.4 4.20E-02
miR-29b-1-5p 265 Insulin signaling pathway 5 1.9 8.50E-02
Cell cycle 4 1.5 2.00E-01
Wnt signaling pathway 4 1.5 2.90E-01
Jak-STAT signaling pathway 4 1.5 3.00E-01
miR-3663-3p 305 MAPK signaling pathway 12 3.9 5.90E-03
Pathways in cancer 11 3.6 5.50E-02
Focal adhesion 7 2.3 1.30E-01
Cytokine-cytokine receptor interaction 7 2.3 3.00E-01
miR-371a-5p 351 Spliceosome 8 2.3 4.20E-03
Wnt signaling pathway 7 2 3.60E-02
miR-4327 112 MAPK signaling pathway 4 3.6 1.20E-01
Pathways in cancer 4 3.6 1.80E-01
Melanoma 3 2.7 4.00E-02
Calcium signaling pathway 3 2.7 1.90E-01
miR-584-5p 288 MAPK signaling pathway 8 2.8 9.70E-02
Pathways in cancer 8 2.8 2.10E-01
miR-602 302 MAPK signaling pathway 7 2.3 2.20E-01
Insulin signaling pathway 6 2 5.30E-02
Alzheimer’s disease 6 2 1.00E-01
Calcium signaling pathway 6 2 1.30E-01
miR-629-3p 445 Pathways in cancer 10 2.3 2.10E-01
miR-642b-3p 262 Glioma 4 1.5 3.20E-02
Melanoma 4 1.5 4.30E-02
Cell adhesion molecules 5 1.8 5.70E-02
miR-651 60 Calcium signaling pathway 3 4.3 5.40E-01
Ubiquitin mediated proteolysis 3 4.3 6.00E-02
Regulation of autophagy 2 2.9 9.90E-02
miR-762 534 Axon guidance 16 3 6.60E-07
MAPK signaling pathway 16 3 2.90E-03
Wnt signaling pathway 13 2.4 4.00E-04
miR-874 176 B and T cell receptor signaling pathway 4 2.3 2.20E-02
MAPK signaling pathway 4 2.3 3.70E-01
mir-890 325 Wnt signaling pathway 7 2.1 6.50E-02
ErbB signaling pathway 5 1.5 8.10E-02
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Table 4 Main functions of upregulated miRNAs predicted by bioinformatic analysis (Continued)
miR-939 365 Calcium signaling pathway 10 2.4 1.30E-02
ErbB signaling pathway 5 1.2 1.20E-01
p53 signaling pathway 4 0.9 1.80E-01
Wnt signaling pathway 6 1.4 2.20E-01
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Cell culture and reagents
HHDPCs provided by Innoprot (Bizkaia, Spain) were pur-
chased and maintained in Dulbecco’s modified Eagle’s
medium (DMEM) containing 10% fetal bovine serum
(HyClone; Thermo Fisher Scientific Inc., Waltham, MA,
USA) and 1% penicillin-streptomycin (Gibco; Life Tech-
nologies, Grand Island, NY, USA) at 37°C and 5% CO2.
Arctiin, propidium iodide (PI) for cell cycle analysis and 2′
7′-dichlorofluorescein diacetate (DCF-DA) for intracellular
ROS analysis were purchased from Sigma-Aldrich (St.
Louis, MO, USA).Table 5 Main functions of downregulated miRNAs predicted b
miRNA Putative
target genes KEGG pathway(Homo sapiens)





miR-1915-3p 351 Wnt signaling pathway
Pathways in cancer
miR-2861 170 Fc gamma R-mediated phagocy
MAPK signaling pathway
Arachidonic acid metabolism




miR-452-5p 327 Oocyte meiosis
Wnt signaling pathway
ECM-receptor interaction
miR-513a-5p 980 MAPK signaling pathway
Pathways in cancer
Regulation of actin cytoskeleton
miR-572 6 -
miR-629-3p 445 Pathways in cancer
miR-765 548 Cytokine-cytokine receptor inter
miR-875-5p 181 MAPK signaling pathway
Spliceosome
miR-940 - -Water-soluble tetrazolium salt (WST-1) assay
To analyze cell viability, HHDPCs were plated on 96-
well culture dishes. After overnight growth, the cells
were treated with various concentrations of arctiin
(0–60 μM) for 24 h. WST-1 assay solution (EZ-Cytox
Cell Viability Assay Kit, Itsbio, Seoul, Korea) was
added for 40 min after the 24-h incubation. Cell via-
bility was measured using an iMark microplate reader
(Bio-Rad, Hercules, CA, USA) at 490 nm with a ref-
erence filter of 620 nm. The results are presented as
mean percentage ± standard deviation (S.D.) of three
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To analyze cells in different phases of the cell cycle,
treated HHDPCs (4 × 103) were gathered by trypsiniza-
tion and fixed by adding cold 70% ethanol at −20°C for
1 h. After fixation, cells were stained by incubating with
PI staining solution (50 μg/ml PI, 0.5% Triton X-100,
and 100 μg/ml RNase) at 37°C for 1 h. The distribution
of each cell cycle phase was determined by evaluating
the intensity of fluorescence PI staining using the FL2-H
channel of a FACSCalibur (BD Biosciences, Franklin
Lakes, NJ, USA).
DCF-DA-based ROS analysis
To analyze intracellular ROS levels in HHDPCs, treated
cells were washed, trypsinized, and collected. Cells were
diluted in 20 μM DCF-DA/phosphate-buffered saline
(PBS) and incubated at room temperature for 1 h in the
dark. After incubation, cells were washed once with
PBS and subjected to flow cytometer-based fluorescence
analysis using a BD FACSCalibur flow cytometer (BD
Biosciences).
β-galactosidase (β-Gal)-based cellular senescence analysis
To analyze the level of cellular senescence in HHDPCs
after arctiin and H2O2 treatment, treated cells were gath-
ered and fixed by the addition of 2% formaldehyde/0.2%
glutaraldehyde. After fixation, senescence-associated
β-galactosidase (SA-β-Gal) staining solution (Biovision,
Milpitas, CA, USA) was added to the fixed cells and in-
cubated at 37°C overnight. Senescent cells (positive blue
color) were observed and counted using a bright-field
microscope at × 200 magnification, and the percentages
were determined.
Microarray-based miRNA expression analysis
To investigate which miRNAs are altered in our study,
treated HHDPCs were gathered and lysed using TRIzol
reagent (Life Technologies) for total RNA purification.
Total RNA was extracted from the lysed cells according
to the manufacturer’s protocol and estimated its integ-
rity and purity was estimated using an Agilent 2100
Bioanalyzer® (Agilent Technologies, Santa Clara, CA, USA)
and a MaestroNano® microvolume spectrophotometer
(Maestrogen, Las Vegas, NV, USA). We confirmed that the
RNA samples had values integrity values higher than 8.0
and A260/280 and A260/230 values greater than 1.8. The
qualified RNA samples were subjected to miRNA micro-
array analysis as described previously [40]. Briefly, RNAs
were dephosphorylated and labeled with cyanine 3-pCp
(Agilent Technologies). The labeled samples were dried
and treated with GE Blocking Agent (Agilent Technolo-
gies) to reduce background or nonspecific binding to the
probe onto the microarray. Then, the samples were hybrid-
ized to the SurePrint G3 Human v16 miRNA 8x60Kmicroarray (Agilent Technologies) in the Agilent Micro-
array Hybridization Chamber (Agilent Technologies) for
20 h. After hybridization, the array was scanned using an
Agilent SureScan Microarray Scanner (Agilent Technolo-
gies) and quantitated using Agilent Feature Extraction
Software (version 10.7, Agilent Technologies). Derived data
were analyzed using GeneSpring GX software, version 11.5
(Agilent Technologies). The data were filtered using flag-
present and t-tests to identify miRNAs for further analysis.
miRNA expression was evaluated by assessing the fluores-
cence ratio between two samples. Those displaying >2.0-
fold increases or decreases were selected for further
bioinformatic analysis.
Bioinformatical tool-based biological analysis of miRNAs
To investigate the biological meaning of miRNAs with sig-
nificantly altered expression, we used three kinds of bioin-
formatical tools: MicroCosm Targets Version 5 (http://
www.ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/),
AmiGo 2 GO analysis tool and DAVID (Database for An-
notation, Visualization and Interrogate Discovery, http://
david.abcc.ncifcrf.gov/home.jsp) bioinformatics resources
v6.7 [41]. Using the first tool, we predicted the putative
target genes of the altered miRNAs, and the second tool
was used to group target genes into four categories: aging,
skin development, apoptosis, and cell proliferation. Finally,
the targets were analyzed using the Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathway-based enrichment
analysis program in the bioinformatic database DAVID.
The Ensembl transcript ID lists of target genes were gath-
ered and subjected to pathway analysis using the KEGG
program in DAVID bioinformatic resources. The Ease
score, which is a modified Fisher’s extract P-value, was
fixed at 0.5 and meaningful KEGG pathways showing a
value of >0.9% (percentage of involved target genes/total
target genes) were selected.
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